Around the Precinct – 26 May 2022

In 2019, one in every five Australian clinical trials was commenced or continued here on the Alfred precinct. Three years later we are still one of the leading clinical trial sites in the country, as recognised this week with not one but two awards from the Australian Clinical Trials Alliance (ACTA), including the prestigious Trial of the Year for the REMAP-CAP study into treatments for COVID-19. 

This week we also congratulate Professor Susan Davis AO, Head of the Women’s Health Research Program at Monash SPHPM, who has received the annual College Medal from the Royal Australian College of Physicians.

Elsewhere on the precinct, our partners are looking ahead to Reconciliation Week (27 May to 3 June) and reflecting on how we can all contribute to a more inclusive future inspired by this year’s theme of “Be Brave. Make Change.” 

Monash REMAP-CAP clinical trial

The Monash-led REMAP-CAP study has been named Trial of the Year at the Australian Clinical Trials Alliance annual awards.

Alfred Health

Thumbs up for over 300 volunteers
If you’ve visited The Alfred at some point over the last 20 years, chances are you’ve been greeted by a very friendly face.
Read more

Monash University – Central Clinical School

Monash-led PADDI trial wins award
The Perioperative Administration of Dexamethasone and Infection (PADDI) trial has been honoured by the 2022 Australian Clinical Trials Alliance (ACTA) Excellence in Trial Statistics Award.
Read more

Acknowledging, respecting and supporting the diversity and inclusivity of LGBTQIA+ at the Central Clinical School
17 May is an important date for us all to recognise the International Day Against Homophobia, Biphobia, Interphobia and Transphobia (IDAHOBIT). Since its establishment in 2004, commemorations have taken place in more than 132 countries globally.
Read more

Nerve stimulation may be potential therapy for leaky gut diseases
Research by Monash Central Clinical School scientists has suggested that stimulating the vagal nerve transcutaneously improves gut permeability and could potentially counter diseases caused by intestinal barrier dysfunction or ‘leaky gut’.
Read more

Hot topics in MS research: our take on the 2022 MS Australia Scientific Conference
Michael and I are third year PhD students in the Multiple Sclerosis and Neuroimmunology (MSNI) Genomics and Prognostics Group, led by Dr Vilija Jokubaitis. We recently attended the 2022 Progress in MS Research Scientific Conference in Hobart, convened by Prof. Helmut Butzkueven, Head of the Department of Neuroscience, Central Clinical School to present some of our work with academic peers and the wider non-academic community.
Read more

Monash University – School of Public Health and Preventive Medicine

Duplicative and out of date: systematic reviews of remdesivir highlight wasted research on COVID-19
Systematic reviews of the antiviral drug remdesivir featured considerable duplication, and half were already out of date at the time of publication, according to a recent investigation by Cochrane Australia published in the Journal of Clinical Epidemiology.
Read more

COVID study wins Trial of the Year award
The incredible contributions to understanding how to treat COVID made by the REMAP-CAP trial have been recognised, as the researchers walked away from yesterday’s Australian Clinical Trials Alliance annual award ceremony with the Trial of the Year Award.
Read more

Supporting better healthcare for immunocompromised youth
Adolescents and young adults have been hard hit by the COVID-19 pandemic. It’s severely disrupted education, thwarted important socialisation opportunities and life milestone celebrations, and employment opportunities have evaporated as a consequence of it.
Read more

RACP College Medal awarded to renowned women’s health researcher
Huge congratulations to the Head of our Women’s Health Research Program, researcher and endocrinologist Professor Susan Davis AO, on recently receiving the annual College Medal from the Royal Australian College of Physicians.
Read more

Burnet Institute

Burnet support for National Reconciliation Week
National Reconciliation Week is a time for all Australians to reflect on what reconciliation means to us and how we can contribute to achieving reconciliation in Australia.
Read more

Reducing COVID transmission by 20 per cent could save 2000 Australian lives this year
Burnet’s Know-C19 team – Professors Margaret Hellard AM and Brendan Crabb AC, Dr Nick Scott and Dominic Delport, explain in The Conversation.
Read more